Navigation Links
Pharmacyclics Announces Date of Fourth Quarter and Fiscal Year End 2009 Conference Call
Date:9/14/2009

SUNNYVALE, Calif., Sept. 14 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated diseases and cancer, today announced that it will report financial results for the fourth quarter and fiscal year ended June 30, 2009 after the NASDAQ market closes on Thursday September 17, 2009 at 1:30 p.m. PDT (4:30 p.m. EDT). To participate in the conference call, please dial 866-642-7062 for domestic callers and 706-643-1591 for international callers. The conference ID is 30472935. To access the audio broadcast or the subsequent archived recording, log on to http://ir.pharmacyclics.com/events.cfm. The archived version of the webcast will be available on the company's website for one month.

About Pharmacyclics

Pharmacyclics(R) is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune mediated disease and cancer. The purpose of the company is to create a profitable business by generating income from products it develops, licenses and commercializes, either with one or several potential partners or alone as may best forward the economic interest of its stakeholders. The Company endeavors to create novel, patentable, differentiated products that have the potential to significantly improve the standard of care in the markets it serves. Presently, Pharmacyclics has four product candidates in clinical development and two product candidates in pre-clinical development. It is Pharmacyclics' business strategy to establish collaborations with large pharmaceutical and biotechnology companies for the purpose of generating present and future income in exchange for adding
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmacyclics to Present and Webcast at Upcoming Life Sciences Investor Conferences
2. Pharmacyclics, Inc. Rights Offering Oversubscribed
3. Pharmacyclics Announces Subscription Price for Rights Offering
4. Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference
5. Pharmacyclics Files Registration Statement for Rights Offering
6. Pharmacyclics Reports Second Quarter Fiscal 2009 Financial Results
7. Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth
8. Pharmacyclics Secures $5.0 Million in Debt Financing
9. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
10. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
11. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015 Research presented at the 2015 ... on the studies that led to a fingerprick Ebola ... this disease to receive approval from the World Health ... Ebola,s grip on West Africa ... healthcare workers to isolate and treat these patients much ...
(Date:7/27/2015)... NEW YORK , July 27, 2015 /PRNewswire-USNewswire/ ... today announced the winners of its annual ... basic research by scientists who have been supported ... early career scientists to pursue innovative ideas in ... generate "proof" of concept for the early detection, ...
(Date:7/27/2015)... Princeton Junction, NJ (PRWEB) , ... July 27, 2015 , ... ... Awards, which identify and celebrate the top 100 most innovative technologies and services of ... ® which was named in the Software/Services category. The winners will be announced at ...
(Date:7/24/2015)... Ryan & Maniskas, LLP that a class action ... the Northern District of California on ... stock of Avalanche Biotechnologies, Inc. ("Avalanche" or the "Company") (NASDAQ: ... 2015, inclusive (the "Class Period"). Avalanche shareholders may, ... appointment as a lead plaintiff of the Class.  If you ...
Breaking Biology Technology:Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 4Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 5Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 6Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3
... Mass. Cat fanciers everywhere appreciate the gravity-defying grace and ... those traits extend even to the way cats lap milk? ... the way domestic and big cats lap and found that ... between two physical forces. The results will be published ...
... heart implanted micro robot operate permanently? Can cell phones and ... their batteries charged? It might sound like science fiction, ... future. The team of Prof. Keon Jae ... Zhong Lin Wang (Georgia Institute of Technology, Dept. of Materials ...
... City, November 11, 2010 Professor Federico Rosei of ... as the recipient of the prestigious 2010 Friedrich Wilhelm ... Foundation. The foundation grants 25 of these awards annually ... Rosei was selected in recognition of the caliber and ...
Cached Biology Technology:Cats show perfect balance even in their lapping 2Cats show perfect balance even in their lapping 3Cats show perfect balance even in their lapping 4New forms of highly efficient, flexible nanogenerator technology 2INRS professor Federico Rosei receives a 2010 Friedrich Wilhelm Bessel Research Award 2
(Date:7/21/2015)... July 21, 2015 Passwords have proven ... in the recent U.S. Office of Personnel Management ... the infosec conundrum, but developers and end-users are ... address this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced ... SDK for third party integration. ...
(Date:7/9/2015)... , July 07, 2015 ... the addition of the "Biometrics for Banking; ... 2015-2020" report to their offering. ... contributor to this growth and the forecast is ... in revenue for companies involved in delivering biometric ...
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... Li et al. explain how prolonged stress sparks the ... cells to undergo apoptosis in several aging-related diseases.The study ... the Journal of Cell Biology (online September ... in the ER. Cells try to recover by slowing ...
... understanding of how anesthesia and anesthesia-like states are controlled ... future treatments of various states of loss of consciousness, ... Jerusalem scientists. In an article published in ... Devor, the Cecile and Seymour Alpert Professor of Pain ...
... The same properties of nanoparticles that make them so ... the environment and human health. However, little is ... problem is determining exactly what a nanoparticle is. ... from the Center for the Environmental Implications of NanoTechnology ...
Cached Biology News:'Alert status' area in brain discoved by Hebrew University scientists 2When nano may not be nano 2When nano may not be nano 3
MHC II (HLA-DP)...
... is a new product number, created to ... no availability yet, please order under the ... service for assistance. ID clarifier: ... H 100 20 mm surface ...
BD BioCoat Laminin 100 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse laminin....
... 5-OxoETE-d7 is used as an internal ... stable isotope dilution mass spectrometry. 5-OxoETE is ... oxidation of 5-HETE in human neutrophils. It ... an EC50 of 2 nM. 5-OxoETE selectively ...
Biology Products: